The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3 '[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agents (Q38449133)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 June 2014
edit
Language Label Description Also known as
English
The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3 '[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agents
scientific article published on 24 June 2014

    Statements

    The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3'[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agents (English)
    Peter B Sampson
    Yong Liu
    Narendra Kumar Patel
    Miklos Feher
    Bryan Forrest
    Sze-Wan Li
    Louise Edwards
    Radoslaw Laufer
    Yunhui Lang
    Fuqiang Ban
    Donald E Awrey
    Guodong Mao
    Olga Plotnikova
    Richard Hodgson
    Jacqueline M Mason
    Xin Wei
    Reza Kiarash
    Erin Green
    Wei Qiu
    Nickolay Y Chirgadze
    Tak W Mak
    Guohua Pan
    Henry W Pauls
    24 June 2014
    130-146

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit